Title:
COMPOSITIONS AND METHODS FOR TREATMENT OF ACHROMOTOPSIA
Document Type and Number:
WIPO Patent Application WO/2024/011109
Kind Code:
A3
Abstract:
Provided is the intravitreal or subretinal dosing of recombinant adeno-associated virus (rAAV)-based gene therapies for the treatment of color vision deficiencies such as achromotopsia.
More Like This:
Inventors:
BELBELLAA BRAHIM (US)
Application Number:
PCT/US2023/069618
Publication Date:
April 11, 2024
Filing Date:
July 05, 2023
Export Citation:
Assignee:
ADVERUM BIOTECHNOLOGIES INC (US)
International Classes:
C07K14/47; A61K9/00; A61K35/761; A61K48/00; A61P27/02; C07K14/705; C12N15/86
Domestic Patent References:
WO2018232149A1 | 2018-12-20 | |||
WO2021126880A1 | 2021-06-24 |
Foreign References:
US9375491B2 | 2016-06-28 | |||
US20200384073A1 | 2020-12-10 | |||
US20150259395A1 | 2015-09-17 | |||
US20140296079A1 | 2014-10-02 | |||
US7371823B2 | 2008-05-13 | |||
US6936704B1 | 2005-08-30 | |||
US20170283496A1 | 2017-10-05 |
Attorney, Agent or Firm:
LEITZEL, Adelaide K. (US)
Download PDF:
Previous Patent: ADDING CONTROL OR MANAGEMENT DATA TO BLOCK ACKNOWLEDGE OR PROTOCOL DATA UNIT
Next Patent: SAFE ACCESS SYSTEM
Next Patent: SAFE ACCESS SYSTEM